Profile for Israel Patent: 277213
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Israel Patent: 277213
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Mar 18, 2039 | Mc2 | WYNZORA | betamethasone dipropionate; calcipotriene |
| ⤷ Start Trial | Mar 18, 2039 | Mc2 | WYNZORA | betamethasone dipropionate; calcipotriene |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
